Xylem Intrinsic value of stock options exercised decreased by 75.0% to $1.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 80.0%, from $5.00M to $1.00M. Over 4 years (FY 2021 to FY 2025), Intrinsic value of stock options exercised shows a downward trend with a -13.7% CAGR.
Higher intrinsic value indicates that employees are realizing significant gains, which may correlate with strong stock performance.
The total intrinsic value realized by employees upon the exercise of stock options during the period, calculated as the...
Often disclosed in the notes to financial statements regarding stock-based compensation.
other_share_based_compensation_arrangement_by_share_base_f4d743| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.80M | $10.00M | $9.90M | $600.00K | $1.50M | $1.10M | $800.00K | $7.00M | $102.00M | $10.00M | $21.00M | $46.00M | $25.00M | $2.00M | $1.00M | $5.00M | $2.00M | $4.00M | $4.00M | $1.00M |
| QoQ Change | — | +108.3% | -1.0% | -93.9% | +150.0% | -26.7% | -27.3% | +775.0% | >999% | -90.2% | +110.0% | +119.0% | -45.7% | -92.0% | -50.0% | +400.0% | -60.0% | +100.0% | +0.0% | -75.0% |
| YoY Change | — | — | — | — | -68.8% | -89.0% | -91.9% | >999% | >999% | +809.1% | >999% | +557.1% | -75.5% | -80.0% | -95.2% | -89.1% | -92.0% | +100.0% | +300.0% | -80.0% |